Alexia Iasonos

27PUBLICATIONS
191CO-AUTHORS
Predictive and prognostic markersForensic epidemiologySatisfiability and optimisationChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Mar 25, 2026
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.

Maria M Rubinstein, Jennifer Y Ge, Qin Zhou

|Jan 29, 2026
Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset Cases.

Judy J Wang, Juliet Milani, Sarah Kane

|Oct 02, 2025
Bringing Trustworthy Artificial Intelligence to the Clinical Forefront at JCO: A Guide for Studies Testing Artificial Intelligence Models.

Ravi B Parikh, Alexia Iasonos, Andrew Ko

|Oct 02, 2025
FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Early-Phase Trials Using Innovative Trial Designs and Biomarkers.

Olanrewaju O Okusanya, Gabriela I Patilea-Vrana, Anthony Sireci

|Sep 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.

Andrea Necchi, Matthew D Galsky, Nazli Dizman

|Jul 15, 2025
Guidance for JCO Authors on Subgroup Representation and Reporting.

Stephanie B Wheeler, Alexia Iasonos, Iona Cheng

Pageof 5

Frequent Collaborators

10 joint publications

Qin Zhou

10 joint publications

Britta Weigelt

7 joint publications

Carol Aghajanian

6 joint publications

Michael F Berger